PBMs to FTC: We are the best hope for lowering prescription drug cost
PBMs are fulfilling their primary mission to lower prescription drug costs for consumers and health plan sponsors, says PCMA CEO.
April 28, 2022
There’s a whole lot going on in the world of pharmacy benefit management and we’re here to tell you all about it. From news about changes in prescription drug approvals, uses and warnings, to deep dives into the business of PBMs, you’ll find it all here.
PBMs are fulfilling their primary mission to lower prescription drug costs for consumers and health plan sponsors, says PCMA CEO.
VativoRx recently participated in the SIIA Future Leaders Forum in April 2022.
Mom and Pop pharmacies are thriving. A recent study showed the number of independent pharmacies in the United States growing 12.9% from 2010 to 2019.
For a lot of people, their first choice is a so-called “Mom and Pop” business that may be slightly smaller and more focused on personal service.
Going forward, generic drugs may be more difficult to manufacture, due to the nature of the medicines they aim to replicate.
While most of us are deeply familiar the patient’s journey, sometimes that process may not be as clear as it could be.
At a recent industry conference, the number one topic attendees wanted to learn more about was price transparency.
For the past year, we’ve been working with an independent video producer to create and air a short-form video segment about how PBMs can do better.
We’re now living in a golden age of generic prescription drugs.
12000 Biscayne Blvd, Suite 800
Miami, FL 33181
TF: 888-488-5750
F: 786-254-7695
12000 Biscayne Blvd, Suite 800 Miami, FL 33181
TF: 888-488-5750 | F: 786-254-7695